JingXia Cui
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
- Biomaterials 16
- Nanoparticle-Based Drug Delivery 15
-
- RNA Interference and Gene Delivery 6
- Natural product bioactivities and synthesis 2
- Protein purification and stability 2
- Co-authors
- Yanhui Li (13 shared papers)Caixia Wang (11 shared papers)Chunlei Li (12 shared papers)Chunlei Li (6 shared papers)Lan Zhang (8 shared papers)Li Zhang (8 shared papers)Yongli Wang (5 shared papers)Na Wei (8 shared papers)
- Journals
- International Journal of Pharmaceutics (7 papers)Journal of Pharmacy and Pharmacology (5 papers)Cell Proliferation (2 papers)Journal of Pharmaceutical Sciences (2 papers)Current Pharmaceutical Biotechnology (1 paper)
- Partner nations
- ChinaSouth Korea
In The Last Decade
JingXia Cui
28 papers receiving 757 citations
Peers
Comparison fields: 5 of 92
- Biomaterials 374
- Pharmaceutical Science 101
- Molecular Medicine 40
- Molecular Biology 377
- Biomedical Engineering 150
Countries citing papers authored by JingXia Cui
This map shows the geographic impact of JingXia Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JingXia Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JingXia Cui more than expected).
Fields of papers citing papers by JingXia Cui
This network shows the impact of papers produced by JingXia Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JingXia Cui. The network helps show where JingXia Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside JingXia Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 99 | |
| 2 | 2014 | 73 | |
| 3 | 2006 | 52 | |
| 4 | 2012 | 49 | |
| 5 | 2008 | 42 | |
| 6 | 2013 | 41 | |
| 7 | 2008 | 38 | |
| 8 | 2008 | 35 | |
| 9 | 2018 | 35 | |
| 10 | 2008 | 31 | |
| 11 | 2017 | 30 | |
| 12 | 2011 | 27 | |
| 13 | 2020 | 27 | |
| 14 | 2008 | 23 | |
| 15 | 2011 | 20 | |
| 16 | 2013 | 19 | |
| 17 | 1999 | 19 | |
| 18 | 2018 | 18 | |
| 19 | 2017 | 18 | |
| 20 | 2008 | 17 |
About JingXia Cui
JingXia Cui is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Pulmonary and Respiratory Medicine and Pharmaceutical Science, having authored 28 papers that have together received 765 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (6 papers), Nanoplatforms for cancer theranostics (4 papers), Inhalation and Respiratory Drug Delivery (3 papers), Cancer Treatment and Pharmacology (2 papers), Dendrimers and Hyperbranched Polymers (2 papers), Natural product bioactivities and synthesis (2 papers) and Protein purification and stability (2 papers). The work is most often cited by research in Biomaterials (374 citations), Pharmaceutical Science (101 citations), Molecular Medicine (40 citations), Molecular Biology (377 citations) and Biomedical Engineering (150 citations). JingXia Cui has collaborated with scholars based in China and South Korea. Frequent co-authors include Yanhui Li, Caixia Wang, Chunlei Li, Chunlei Li, Lan Zhang, Li Zhang, Yongli Wang, Na Wei, Wenmin Guo and Long Ma. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmacy and Pharmacology, Cell Proliferation, Journal of Pharmaceutical Sciences and Current Pharmaceutical Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.